206 related articles for article (PubMed ID: 28588023)
1. What is oncolytic virotherapy?
Cockle JV; Scott KJ
Arch Dis Child Educ Pract Ed; 2018 Feb; 103(1):43-45. PubMed ID: 28588023
[No Abstract] [Full Text] [Related]
2. Editorial: oncolytic viruses.
Jia W
Curr Pharm Biotechnol; 2012 Jul; 13(9):1731. PubMed ID: 22856874
[No Abstract] [Full Text] [Related]
3. Viruses: tools for tumor target discovery, and agents for oncolytic therapies - an introduction.
O'Shea CC
Oncogene; 2005 Nov; 24(52):7636-9. PubMed ID: 16299525
[No Abstract] [Full Text] [Related]
4. Future prospects for oncolytic therapy.
McCormick F
Oncogene; 2005 Nov; 24(52):7817-9. PubMed ID: 16299540
[TBL] [Abstract][Full Text] [Related]
5. United virus: the oncolytic tag-team against cancer!
Le Boeuf F; Bell JC
Cytokine Growth Factor Rev; 2010; 21(2-3):205-11. PubMed ID: 20227326
[TBL] [Abstract][Full Text] [Related]
6. Oncolytic virotherapy.
Sze DY; Reid TR; Rose SC
J Vasc Interv Radiol; 2013 Aug; 24(8):1115-22. PubMed ID: 23885911
[TBL] [Abstract][Full Text] [Related]
7. Oncolytic viruses in cancer therapy.
Vähä-Koskela MJ; Heikkilä JE; Hinkkanen AE
Cancer Lett; 2007 Sep; 254(2):178-216. PubMed ID: 17383089
[TBL] [Abstract][Full Text] [Related]
8. Oncolytic viruses as platform for multimodal cancer therapeutics: a promising land.
Guo ZS; Bartlett DL
Cancer Gene Ther; 2014 Jul; 21(7):261-3. PubMed ID: 25034971
[No Abstract] [Full Text] [Related]
9. Clinical development of oncolytic viruses in China.
Liang M
Curr Pharm Biotechnol; 2012 Jul; 13(9):1852-7. PubMed ID: 21740357
[TBL] [Abstract][Full Text] [Related]
10. Targeting pediatric cancer stem cells with oncolytic virotherapy.
Friedman GK; Cassady KA; Beierle EA; Markert JM; Gillespie GY
Pediatr Res; 2012 Apr; 71(4 Pt 2):500-10. PubMed ID: 22430386
[TBL] [Abstract][Full Text] [Related]
11. Recent clinical experience with oncolytic viruses.
Donnelly OG; Errington-Mais F; Prestwich R; Harrington K; Pandha H; Vile R; Melcher AA
Curr Pharm Biotechnol; 2012 Jul; 13(9):1834-41. PubMed ID: 21740364
[TBL] [Abstract][Full Text] [Related]
12. Oncolytic HSV-1 virotherapy: clinical experience and opportunities for progress.
Kaur B; Chiocca EA; Cripe TP
Curr Pharm Biotechnol; 2012 Jul; 13(9):1842-51. PubMed ID: 21740359
[TBL] [Abstract][Full Text] [Related]
13. Attack of the cancer-killing viruses: clinical application of oncolytic virotherapy in children.
Friedman GK
Pediatr Blood Cancer; 2015 May; 62(5):739-40. PubMed ID: 25663349
[No Abstract] [Full Text] [Related]
14. Spatial Model for Oncolytic Virotherapy with Lytic Cycle Delay.
Zhao J; Tian JP
Bull Math Biol; 2019 Jul; 81(7):2396-2427. PubMed ID: 31089864
[TBL] [Abstract][Full Text] [Related]
15. The replicability of oncolytic virus: defining conditions in tumor virotherapy.
Tian JP
Math Biosci Eng; 2011 Jul; 8(3):841-60. PubMed ID: 21675814
[TBL] [Abstract][Full Text] [Related]
16. Advance in herpes simplex viruses for cancer therapy.
Liu S; Dai M; You L; Zhao Y
Sci China Life Sci; 2013 Apr; 56(4):298-305. PubMed ID: 23564184
[TBL] [Abstract][Full Text] [Related]
17. Going viral: a review of replication-selective oncolytic adenoviruses.
Larson C; Oronsky B; Scicinski J; Fanger GR; Stirn M; Oronsky A; Reid TR
Oncotarget; 2015 Aug; 6(24):19976-89. PubMed ID: 26280277
[TBL] [Abstract][Full Text] [Related]
18. Personalizing oncolytic virotherapy?
Kaur B; Chiocca EA
Mol Ther; 2007 Jan; 15(1):6-7. PubMed ID: 17164767
[No Abstract] [Full Text] [Related]
19. Questing for an optimal, universal viral agent for oncolytic virotherapy.
Paiva LR; Martins ML; Ferreira SC
Phys Rev E Stat Nonlin Soft Matter Phys; 2011 Oct; 84(4 Pt 1):041918. PubMed ID: 22181186
[TBL] [Abstract][Full Text] [Related]
20. Translational research in oncolytic measles virotherapy: early discoveries and future steps.
Msaouel P; Opyrchal M; Galanis E
Future Microbiol; 2011 Feb; 6(2):125-8. PubMed ID: 21366411
[No Abstract] [Full Text] [Related]
[Next] [New Search]
